RubiconMD Raises $1.3 Million For Web-Based Specialist Consultations


New York City-based digital health startup RubiconMD has raised a $1.3 million seed round led by Waterline Ventures. The round also included investments from Oxeon Investments, Athenahealth, and a group of angel investors that includes the CEO of Blue Cross Blue Shield of Florida, and the CEO of Henry Ford Medical Group.

The company was founded by a trio of Harvard Alums. Gil Addo, CEO, and Carlos Reines, COO, both graduated from Harvard with MBAs, while Julien Pham, the company’s Chief Medical Officer, received an MPH from Harvard. Prior to joining Rubicon full time, Pham worked at Brigham and Women’s Hospital where he founded and ran its Innovation Lab.

RubiconMD launched in 2013, and was a member of Blueprint Health’s Summer 2014 class. Rubicon’s platform is designed to supplement care delivery by providing primary care doctors with rapid access to specialists who can provide guidance and second opinions. By embedding clinical guidance into the care delivery process, Rubicon hopes its primary care physicians will feel empowered to diagnose and treat at the primary care level, rather than having to refer to specialty care. In its marketing material, Rubicon sites figures suggesting that as many as 40 percent of specialty care visits could have been handled in the primary care setting, which would be a cheaper and more convenient outcome for the patient. If scaled nationally, a system that provides near-immediate specialist recommendations to primary care doctors could help reduce the cost of care, shorten the length of time before a diagnosis is made, and improve the overall patient experience.

Since graduating from Blueprint Health the team has been busy. They formally joined Athenahealth’s More Disruption Please program, released a second generation version of its flagship telehealth software, and raised the capital needed to bring the company to market. In the new platform, specialists are given new features that allow them to share interesting cases with others in their practice, or export the case to outside clinicians so that a multi-specialist team can properly assess the case.

Enjoy HIStalk Connect? Sign up for update alerts, or follow us at @HIStalkConnect.

↑ Back to top

Founding Sponsors

Platinum Sponsors